Authors' Affiliations: 1Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center; 2Department of Biomedical Engineering, Rice University; 3Department of Veterinary Medicine and Surgery, The University of Texas M. D. Anderson Cancer Center; and 4Department of Mechanical Engineering and Materials Science, Rice University, Houston, Texas
Auto-generated profile, based on publicly available information
Catherine Shea Thompson
Authors' Affiliations: 1Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center; 2Department of Biomedical Engineering, Rice University; 3Department of Veterinary Medicine and Surgery, The University of Texas M. D. Anderson Cancer Center; and 4Department of Mechanical Engineering and Materials Science, Rice University, Houston, Texas
There is a paucity of data regarding the safety of administering solid gold nanoparticles (AuNPs) in large animal tumor models. We assessed the acute toxicity and biodistribution of 5 nm and 25 nm solid AuNPs in New Zealand White rabbits (n = 6 in each) with implanted liver Vx2 tumors 24 h after intravenous injection. Gold concentration was determined by inductively coupled plasma atomic emission spectrometry (ICP) and imaged with transmission electron microscopy (TEM). There was no clinico-pathologic evidence of renal, hepatic, pulmonary, or other organ dysfunction. After 25 nm AuNP administration, the concentration of white blood cells increased after treatment (p = 0.001). Most other blood studies were unchanged. AuNPs were distributed to the spleen, liver, and Vx2 tumors, but not to other tissues. The urinary excretion of AuNPs was bimodal as measured by ICP. 25 nm AuNPs were more evenly distributed throughout tissues and may be better tools for medical therapy.